Funds raised on behalf of The Wetzel Foundation will benefit their mission to eradicate ALS and FTD through research donations which help our lab continue our quest to better understand these diseases! Watch the video to see Whit and his family's inspiring journey and consider donating to this great cause.
A study published in the journal Science by researchers from Harvard Medical School has identified a key instigator of nerve cell damage in people with ALS.Finding out more about how this disease starts and progresses is crucial to the development of treatments and cures - having a target to aim for is the most effective way to develop treatments!
An interesting take on media coverage of scientific discoveries. In today's culture of 'clickbait' headlines, news reports of scientific papers' findings may not tell the whole story. However, most of the time it's difficult or impossible to find access to the original publication to get the whole picture. If you or your family have questions about the science behind the media coverage, we are here to discuss the benefit of this or other genetic testing in the context of your family's situation.
Our own laboratory associate director Dr. Han-Xiang Deng was welcomed by the Congressional Biomedical Research Caucus to discuss recent ALS breakthroughs! Dr. Deng discussed how he and his collaborators have identified several ALS genes as well as developed the first ALS mouse models. Both discoveries will help researchers better understand the disease as well as test for efficacious drugs. Click here to watch the video!
Chicago tonight published a story about TMEM230, the gene newly identified by our lab to cause Parkinson's disease. About 15-25% of PD is genetic, and this discovery adds to the growing body of knowledge about neurodegenerative disorders and may provide valuable information to patients and families with this disease. Click here to read the story and learn more.
Great article from The Atlantic about Parkinson's disease which highlights our recent TMEM230 discovery. Click here to read more!
Last week, Dr. Teepu Siddique and Dr. Senda Ajroud-Driss attended the Airlie House ALS Clinical Trials Guidelines workshop held from March 16 to 19 in Warrenton, VA. This is the second Airlie House workshop on ALS; Dr. Siddique also contributed to the first workshop, which was held in 1998 and organized by the late Dr. Theodore L. Munsat.
This workshop aims to renew and update the current ALS Clinical Trials Guidelines so that clinical trials in ALS can continue to improve.
The 35-year partnership between Northwestern University Feinberg School of Medicine and the Les Turner ALS Foundation was strengthened recently with the Foundation’s $10 million commitment to create the Les Turner ALS Research and Patient Center at Northwestern Medicine.
For the full story, please read the March 2015 issue of Northwestern Medicine Philanthropist. For more information about supporting the new Les Turner ALS Research and Patient Center, please contact Courtney Weeks at (312) 503-3080 or firstname.lastname@example.org.
The ALS Surveillance Project recently completed its data collection project to better understand ALS in various metro areas of the United States. The purpose of this project was to obtain reliable and timely information about the incidence and prevalence of ALS and to better describe the demographic characteristics of individuals with ALS in the United States. More information about the project and data for participating metro areas can be found here, while data collected for the Chicago area can be found here.
Genetic counselor Lisa Kinsley gave a talk at the 2014 ALS Association's Clinical Conference in Phoenix, Arizona. Her talk focused on the utility of genetic counseling services for both sporadic and familial ALS patients, and the benefits genetic counselors can provide when obtaining family history information, determining the utility of genetic testing, and providing information about the testing process and the psychosocial impact of testing for both patients and unaffected family members. She also reviewed family planning options for families with a known mutation, including testing a pregnancy or even an embryo before it is implanted. The talk was well-received.